Tuesday, April 28, 2020

Glenmark Pharma gets tentative USFDA nod for generic anti-diabetes tablets

Glenmark Pharma gets tentative USFDA nod for generic anti-diabetes tablets The approval granted by the United States Food and Drug Administration (USFDA) to Glenmark Pharmaceuticals Inc., USA, is for the strength of 10 mg/5 mg tablets, the generic version of Qtern tablets of the same strength of AstraZeneca AB, the company said in a statement.

from Moneycontrol Business News https://ift.tt/3d02wA2
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Paras Defence shares soar 10% as Q2 net profit jumps 50% to Rs 14 crore

Paras Defence and Space Technologies shares surged following strong September quarter results, with net profit jumping 50% and revenue climb...